Rosary Hall Presents Educational Opportunity For HR, EAP, Counseling Professionals

Cleveland, OH (September 8, 2002) - Rosary Hall, the alcohol and other drug treatment facility at St. Vincent Charity Hospital, will present "Opiate Addiction, Treatment Approaches and Relapse Prevention" October 9 from 8 a.m. until 12 Noon at Rosary Hall, St. Vincent Charity Hospital, 2351 East 22nd Street, Cleveland.

The half-day seminar will help conference participants understand the new chemical treatments for opiate addiction, as well as the role of group therapy in a treatment situation. Presenters include Theodore Parran, Jr. MD, Associate Medical Director of Rosary Hall; Chris Adelman, MD, Medical Director of Rosary Hall, and Cynthia Downing, Ph.D., author of Triad: The Evolution of Treatment for Chemical Dependency.

Discussions will center around the Buphrenorphine Maintenance Program, a soon-to-be released treatment program designed by the FDA to combat heroin addiction, as well as the role of the naltrexone pellet, a surgically implantable therapy that blocks drug cravings for as long as 75 days. Dr. Downing will present an hour-long session focusing on the role of long-term group therapy for relapse prevention.

Celebrating its 50th year, Rosary Hall at St. Vincent Charity Hospital is well-known for its effective combination of innovative medical and spiritual care. Rosary Hall is a leader in the field of addiction treatment, establishing Ohio's first in patient treatment program.

The "Opiate Addiction, Treatment Approaches and Relapse Prevention" program runs from 8:00 a.m. to noon on October 9, in the St. Vincent De Paul Room at St. Vincent Charity Hospital. There is no cost to attend. Participants must register by October 1, by calling Marty Prendergast at 216.363.2614 or via email: Marty.Prendergast@csauh.com